Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Invested Capital (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Return on Invested Capital for 15 consecutive years, with 0.94% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital fell 86.0% to 0.94% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.94%, a 86.0% decrease, with the full-year FY2024 number at 0.02%, down 2.0% from a year prior.
  • Return on Invested Capital was 0.94% for Q3 2025 at Harvard Bioscience, up from 0.96% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q1 2021 to a low of 0.96% in Q2 2025.
  • A 5-year average of 0.17% and a median of 0.03% in 2022 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: increased 6bps in 2023, then plummeted -90bps in 2025.
  • Harvard Bioscience's Return on Invested Capital stood at 0.0% in 2021, then plummeted by -1446bps to 0.02% in 2022, then soared by 103bps to 0.0% in 2023, then plummeted by -5356bps to 0.02% in 2024, then plummeted by -3751bps to 0.94% in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Return on Invested Capital are 0.94% (Q3 2025), 0.96% (Q2 2025), and 0.66% (Q1 2025).